We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$268M
AUM Growth
-$59.5M
Cap. Flow
-$50.9M
Cap. Flow %
-19%
Top 10 Hldgs %
44.52%
Holding
92
New
17
Increased
19
Reduced
32
Closed
23

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$9.9M
2
ABT icon
Abbott
ABT
+$8.03M
3
JNJ icon
Johnson & Johnson
JNJ
+$7.21M
4
BDX icon
Becton Dickinson
BDX
+$6.5M
5
ELV icon
Elevance Health
ELV
+$5.07M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$9.44M
2
DHR icon
Danaher
DHR
+$9.11M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$7.69M
4
BBH icon
VanEck Biotech ETF
BBH
+$6.22M
5
SBRA icon
Sabra Healthcare REIT
SBRA
+$6.16M

Sector Composition

Rank Sector Weight
1 Healthcare 93.35%
2 Real Estate 1.88%
3 Financials 1.53%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
76
Edwards Lifesciences
EW
$51.6B
– –
-36,648
Closed -$1.38M
HUM icon
77
Humana
HUM
$43.5B
– –
-6,800
Closed -$1.69M
INSM icon
78
Insmed
INSM
$21.4B
– –
-22,910
Closed -$714K
MEDP icon
79
Medpace
MEDP
$16.1B
– –
-63,100
Closed -$2.29M
SPRO icon
80
Spero Therapeutics
SPRO
$71.2M
– –
-31,100
Closed -$365K
SRPT icon
81
Sarepta Therapeutics
SRPT
$1.73B
– –
-48,800
Closed -$2.71M
SYK icon
82
Stryker
SYK
$129B
– –
-17,867
Closed -$2.77M
TCMD icon
83
Tactile Systems Technology
TCMD
$680M
– –
-50,900
Closed -$1.48M
IMGN
84
DELISTED
Immunogen Inc
IMGN
– –
-210,800
Closed -$1.35M
AERI
85
DELISTED
Aerie Pharmaceuticals
AERI
– –
-45,366
Closed -$2.71M
VCRA
86
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-32,500
Closed -$982K
DRNA
87
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-18,837
Closed -$170K
ARA
88
DELISTED
American Renal Associates Holdings, Inc
ARA
– –
-89,129
Closed -$1.55M
ENTL
89
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-189,268
Closed -$4.62M
OMED
90
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-139,100
Closed -$570K
BHVN
91
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-10,300
Closed -$278K
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Endurant Capital Management held 92 positions worth $268M, down 18% from $327M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Endurant Capital Management withdrew a net $50.9M in Q1 2018, closing 23 positions and reducing 32 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $6.22M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 86% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Endurant Capital Management opened a new position in Universal Health Services worth $9.88M.

  • Endurant Capital Management's largest Q1 2018 buy was Universal Health Services: 83,400 shares worth $9.88M.
  • Endurant Capital Management added most to Abbott in Q1 2018, an estimated $8.03M increase.
  • Endurant Capital Management's biggest Q1 2018 reduction was McKesson, cutting an estimated $9.44M.
  • Endurant Capital Management fully exited VanEck Biotech ETF in Q1 2018, selling an estimated $6.22M.
  • Endurant Capital Management's ten largest holdings make up 45% of its $268M portfolio in Q1 2018.
  • Endurant Capital Management opened 17 new positions and closed 23 in Q1 2018.
  • Endurant Capital Management's portfolio value fell 18% quarter-over-quarter to $268M.

Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.